Published in J Gen Virol on October 01, 2004
Inhibition of NF-kappaB activation in vivo impairs establishment of gammaherpesvirus latency. PLoS Pathog (2007) 1.39
Murid Gammaherpesvirus Latency-Associated Protein M2 Promotes the Formation of Conjugates between Transformed B Lymphoma Cells and T Helper Cells. PLoS One (2015) 1.38
Gammaherpesvirus-driven plasma cell differentiation regulates virus reactivation from latently infected B lymphocytes. PLoS Pathog (2009) 1.23
The MHV68 M2 protein drives IL-10 dependent B cell proliferation and differentiation. PLoS Pathog (2008) 1.11
Activation of Vav by the gammaherpesvirus M2 protein contributes to the establishment of viral latency in B lymphocytes. J Virol (2006) 1.11
Role for MyD88 signaling in murine gammaherpesvirus 68 latency. J Virol (2008) 1.05
Deregulation of DNA damage signal transduction by herpesvirus latency-associated M2. J Virol (2006) 1.04
Virus-encoded microRNAs facilitate gammaherpesvirus latency and pathogenesis in vivo. MBio (2014) 1.04
The Gammaherpesvirus m2 protein manipulates the Fyn/Vav pathway through a multidocking mechanism of assembly. PLoS One (2008) 1.03
NF-kappaB p50 plays distinct roles in the establishment and control of murine gammaherpesvirus 68 latency. J Virol (2009) 0.97
A gammaherpesvirus cooperates with interferon-alpha/beta-induced IRF2 to halt viral replication, control reactivation, and minimize host lethality. PLoS Pathog (2011) 0.93
Use of a virus-encoded enzymatic marker reveals that a stable fraction of memory B cells expresses latency-associated nuclear antigen throughout chronic gammaherpesvirus infection. J Virol (2010) 0.92
Identification of closely spaced but distinct transcription initiation sites for the murine gammaherpesvirus 68 latency-associated M2 gene. J Virol (2008) 0.90
Chemokine binding protein M3 of murine gammaherpesvirus 68 modulates the host response to infection in a natural host. PLoS Pathog (2011) 0.89
A single CD8+ T cell epitope sets the long-term latent load of a murid herpesvirus. PLoS Pathog (2008) 0.89
Characterization of a novel wood mouse virus related to murid herpesvirus 4. J Gen Virol (2009) 0.87
Role of Src homology domain binding in signaling complexes assembled by the murid γ-herpesvirus M2 protein. J Biol Chem (2012) 0.85
Establishment of murine gammaherpesvirus latency in B cells is not a stochastic event. PLoS Pathog (2014) 0.82
Defining immune engagement thresholds for in vivo control of virus-driven lymphoproliferation. PLoS Pathog (2014) 0.76
Type I Interferons Direct Gammaherpesvirus Host Colonization. PLoS Pathog (2016) 0.76
Interferon-regulatory-factor 1 controls Toll-like receptor 9-mediated IFN-beta production in myeloid dendritic cells. Eur J Immunol (2007) 2.62
Design and pre-clinical evaluation of a universal HIV-1 vaccine. PLoS One (2007) 2.61
The alarmin interleukin-33 drives protective antiviral CD8⁺ T cell responses. Science (2012) 2.10
Anthracyclines induce DNA damage response-mediated protection against severe sepsis. Immunity (2013) 1.83
Selective gene expression of latent murine gammaherpesvirus 68 in B lymphocytes. J Virol (2003) 1.64
ORF73 of murine herpesvirus-68 is critical for the establishment and maintenance of latency. J Gen Virol (2003) 1.49
Immune mechanisms in murine gammaherpesvirus-68 infection. Viral Immunol (2005) 1.42
SAMHD1-dependent retroviral control and escape in mice. EMBO J (2013) 1.36
Glycosaminoglycan interactions in murine gammaherpesvirus-68 infection. PLoS One (2007) 1.31
Protective efficacy of serially up-ranked subdominant CD8+ T cell epitopes against virus challenges. PLoS Pathog (2011) 1.27
Long peptides induce polyfunctional T cells against conserved regions of HIV-1 with superior breadth to single-gene vaccines in macaques. Eur J Immunol (2010) 1.27
In vivo imaging of murid herpesvirus-4 infection. J Gen Virol (2009) 1.21
TLR9 contributes to antiviral immunity during gammaherpesvirus infection. J Immunol (2008) 1.20
Murine gammaherpesvirus 68 bcl-2 homologue contributes to latency establishment in vivo. J Gen Virol (2005) 1.19
Herpes simplex virus type 1 latently infected neurons differentially express latency-associated and ICP0 transcripts. J Virol (2006) 1.17
Forced lytic replication impairs host colonization by a latency-deficient mutant of murine gammaherpesvirus-68. J Gen Virol (2004) 1.17
Histone modifications associated with herpes simplex virus type 1 genomes during quiescence and following ICP0-mediated de-repression. J Gen Virol (2008) 1.12
The molecular basis of herpes simplex virus latency. FEMS Microbiol Rev (2012) 1.12
Elevated chemokine responses are maintained in lungs after clearance of viral infection. J Virol (2002) 1.07
Chemokine receptor CCR7 contributes to a rapid and efficient clearance of lytic murine gamma-herpes virus 68 from the lung, whereas bronchus-associated lymphoid tissue harbors virus during latency. J Immunol (2009) 1.06
Superior induction of T cell responses to conserved HIV-1 regions by electroporated alphavirus replicon DNA compared to that with conventional plasmid DNA vaccine. J Virol (2012) 1.03
The Gammaherpesvirus m2 protein manipulates the Fyn/Vav pathway through a multidocking mechanism of assembly. PLoS One (2008) 1.03
Prime-boost regimens with adjuvanted synthetic long peptides elicit T cells and antibodies to conserved regions of HIV-1 in macaques. AIDS (2012) 1.02
Identification and analysis of expression of novel microRNAs of murine gammaherpesvirus 68. J Virol (2010) 1.02
A historical analysis of herpes simplex virus promoter activation in vivo reveals distinct populations of latently infected neurones. J Gen Virol (2008) 1.01
The herpes simplex virus-1 transactivator infected cell protein-4 drives VEGF-A dependent neovascularization. PLoS Pathog (2011) 1.00
A gammaherpesvirus G protein-coupled receptor homologue is required for increased viral replication in response to chemokines and efficient reactivation from latency. J Immunol (2003) 1.00
A battle for survival: immune control and immune evasion in murine gamma-herpesvirus-68 infection. Microbes Infect (2002) 1.00
Safety and immunogenicity of novel recombinant BCG and modified vaccinia virus Ankara vaccines in neonate rhesus macaques. J Virol (2010) 0.99
A systematic analysis of host factors reveals a Med23-interferon-λ regulatory axis against herpes simplex virus type 1 replication. PLoS Pathog (2013) 0.98
A structural basis for BRD2/4-mediated host chromatin interaction and oligomer assembly of Kaposi sarcoma-associated herpesvirus and murine gammaherpesvirus LANA proteins. PLoS Pathog (2013) 0.96
Herpes simplex virus 1 targets the murine olfactory neuroepithelium for host entry. J Virol (2013) 0.96
Optimizing HIV-1-specific CD8+ T-cell induction by recombinant BCG in prime-boost regimens with heterologous viral vectors. Eur J Immunol (2011) 0.95
Transcription of the murine gammaherpesvirus 68 ORF73 from promoters in the viral terminal repeats. J Gen Virol (2005) 0.94
In vivo function of a gammaherpesvirus virion glycoprotein: influence on B-cell infection and mononucleosis. J Virol (2004) 0.93
Dual neonate vaccine platform against HIV-1 and M. tuberculosis. PLoS One (2011) 0.93
Interferon alpha induces establishment of alphaherpesvirus latency in sensory neurons in vitro. PLoS One (2010) 0.92
Testing for herpesvirus infection is essential in children with chromosomal-instability syndromes. J Virol (2013) 0.91
The limits of protection by "memory" T cells in Ig-/- mice persistently infected with a gamma-herpesvirus. Proc Natl Acad Sci U S A (2004) 0.91
Murine gammaherpesvirus-68 infection alters self-antigen presentation and type 1 diabetes onset in NOD mice. J Immunol (2007) 0.90
Characterization of a neurovirulent aciclovir-resistant variant of herpes simplex virus. J Gen Virol (2003) 0.90
A heparan-dependent herpesvirus targets the olfactory neuroepithelium for host entry. PLoS Pathog (2012) 0.90
An investigation of herpes simplex virus promoter activity compatible with latency establishment reveals VP16-independent activation of immediate-early promoters in sensory neurones. J Gen Virol (2011) 0.89
Vaccine potential of a murine gammaherpesvirus-68 mutant deficient for ORF73. J Gen Virol (2004) 0.88
The viral chemokine MCK-2 of murine cytomegalovirus promotes infection as part of a gH/gL/MCK-2 complex. PLoS Pathog (2013) 0.88
Canine embryo-derived stem cells and models for human diseases. Hum Mol Genet (2008) 0.88
Characterization of a novel wood mouse virus related to murid herpesvirus 4. J Gen Virol (2009) 0.87
CD8(+) T cells from mice transnuclear for a TCR that recognizes a single H-2K(b)-restricted MHV68 epitope derived from gB-ORF8 help control infection. Cell Rep (2012) 0.86
Permissive and restricted virus infection of murine embryonic stem cells. J Gen Virol (2012) 0.86
HSV1 latency sites after inoculation in the lip: assessment of their localization and connections to the eye. Invest Ophthalmol Vis Sci (2003) 0.86
Identification of a region of the virus genome involved in murine gammaherpesvirus 68-induced splenic pathology. J Gen Virol (2004) 0.84
Canine embryo-derived stem cells--toward clinically relevant animal models for evaluating efficacy and safety of cell therapies. Stem Cells (2007) 0.84
Control of Rta expression critically determines transcription of viral and cellular genes following gammaherpesvirus infection. J Gen Virol (2007) 0.84
Vaccination with a modified vaccinia virus Ankara (MVA)-vectored HIV-1 immunogen induces modest vector-specific T cell responses in human subjects. Vaccine (2010) 0.82
Protective vaccination with hepatitis C virus NS3 but not core antigen in a novel mouse challenge model. J Gene Med (2008) 0.82
Recombinant murine gammaherpesvirus 68 (MHV-68) as challenge virus to test efficacy of vaccination against chronic virus infections in the mouse model. Vaccine (2007) 0.81
HSV vector-delivery of GDNF in a rat model of PD: partial efficacy obscured by vector toxicity. Brain Res (2004) 0.81
Murine gammaherpesvirus 68 glycoprotein 150 does not contribute to latency amplification in vivo. Virol J (2012) 0.80
A gammaherpesviral internal repeat contributes to latency amplification. PLoS One (2007) 0.80
A gammaherpesvirus complement regulatory protein promotes initiation of infection by activation of protein kinase Akt/PKB. PLoS One (2010) 0.80
Vaccination against a hit-and-run viral cancer. J Gen Virol (2010) 0.79
Direct acoustic profiling of DNA hybridisation using HSV type 1 viral sequences. Analyst (2007) 0.78
In vivo attenuation of recombinant murine gammaherpesvirus 68 (MHV-68) is due to the expression and immunogenicity but not to the insertion of foreign sequences. Virology (2008) 0.78
Does early family risk and current quality of care predict indiscriminate social behavior in institutionalized Portuguese children? Attach Hum Dev (2014) 0.77
BAFF receptor deficiency limits gammaherpesvirus infection. J Virol (2014) 0.76
Diverse physical growth trajectories in institutionalized Portuguese children below age 3: relation to child, family, and institutional factors. J Pediatr Psychol (2012) 0.76
Comment on "Induction of TGF-beta 1, not regulatory T cells, impairs antiviral immunity in the lung following bone marrow transplant". J Immunol (2010) 0.75
Transient IL-10 receptor blockade can enhance CD8(+) T cell responses to a simian adenovirus-vectored HIV-1 conserved region immunogen. Hum Vaccin Immunother (2015) 0.75
Systemic and local infection routes govern different cellular dissemination pathways during gammaherpesvirus infection in vivo. J Virol (2013) 0.75
Correction: Murid Gammaherpesvirus Latency-Associated Protein M2 Promotes the Formation of Conjugates between Transformed B Lymphoma Cells and T Helper Cells. PLoS One (2015) 0.75
A herpesvirus vector can transduce axotomized brain neurons. Exp Neurol (2003) 0.75
Tolerance in DLA-haploidentical canine littermates following CD6-depleted marrow transplantation and donor lymphocyte transfusion. Exp Hematol (2009) 0.75
Transplantation of CD6-depleted peripheral blood stem cells after DLA-haploidentical bone marrow transplantation contributes to engraftment and tolerance in a preclinical model of stem cell transplantation. Vet Immunol Immunopathol (2011) 0.75